Perimeter Enters into Data Transfer Agreement with Columbia University
Toronto, Canada: Sept 21, 2015 – Perimeter Medical Imaging, Inc., a developer of real time imaging systems for in-surgery tumour margin assessment, today announced they have reached a data sharing agreement with Columbia University whereby the company and University will share Optical Coherence Tomography (OCT) image data to accelerate research efforts for high resolution tissue imaging.
Perimeter and Columbia University will utilize current research OCT image databases (from separately conducted clinical studies using excised human breast tissue), including OCT data, histopathology and clinical diagnosis. This data sharing agreement represents an attempt to build cohesive data sets and image libraries to support the great potential of OCT as an effective clinical tool for rapid high resolution tissue imaging.
About Columbia University
A leading academic and research university, Columbia University continually seeks to advance the frontiers of knowledge and to foster a campus community deeply engaged in understanding and addressing the complex global issues of our time. Columbia University’s technology transfer office, Columbia Technology Ventures, manages Columbia’s intellectual property portfolio and serves as the university’s gateway for companies and entrepreneurs seeking novel technology solutions. Our core mission is to facilitate the transfer of inventions from academic research to outside organizations for the benefit of society on a local, national, and global basis. For more information on Columbia Technology Ventures, please visit www.techventures.columbia.edu.
About Perimeter Medical Imaging Inc.
Perimeter Medical Imaging develops, patents and commercializes advanced surgical imaging tools that allow surgeons, radiologists and pathologists to better assess microscopic tissue structures during the surgical procedure. Perimeter’s OTIS™ is the only solution that provides clinicians with an ultra-high resolution image of the entire surface of the removed tissue specimen, providing accurate information in real time, enabling better decisions and ultimately reducing the need for follow-on second surgeries. Perimeter is a privately owned Canadian company. For more information, visit www.perimetermed.com.
Paul Weber, President and CEO
Perimeter Medical Imaging Inc.
* CAUTION - OTIS™ is an investigational device limited by Federal (or United States) law to investigational use.
Released September 15, 2015